Applied Biosciences Corp. (APPB)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
At close: Dec 18, 2025
Applied Biosciences Market Cap
Applied Biosciences has a market cap or net worth of $2.14 thousand as of January 9, 2026. Its market cap has decreased by -99.96% in one year.
Market Cap
2.14K
Enterprise Value
n/a
Revenue
859.86K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 30, 2017, Applied Biosciences's market cap has decreased from 20.01M to 2.14K, a decrease of -99.99%. That is a compound annual growth rate of -64.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 2.14K | -87.50% |
| Dec 23, 2022 | 17.12K | -11.11% |
| Dec 31, 2021 | 19.26K | -97.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 30, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 726.40M |
| Elite Pharmaceuticals | 516.25M |
| Northwest Biotherapeutics | 444.91M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 270.65M |